Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered question first ministerially corrected answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

731348

	registered interest
	date	21/06/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mental Health Services: Children and Young People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he is taking to (a) improve mental health provision and (b) support the needs of children and young people.
	tabling member constituency	Easington
	tabling member printed	Grahame Morris
	uin	328
	answer	answer is ministerial correction date of answer 29/06/2017 answer text <p>We are making £1.4 billion available by 2020 to improve the provision of children and young people’s mental health services (CYP MH), including £<ins class="ministerial">150</ins><del class="ministerial">250</del> million specifically to tackle eating disorders.</p><p> </p><p>This funding is delivering a major system-wide transformation programme to improve access and make services more widely available across the country, and implementing the vision set out in Future in Mind. To this end all clinical commissioning groups working with their partners, developed CYP MH Transformation Plans in 2015/16, incorporating them last year into their wider National Health Service Sustainability and Transformation Plans. These set out how local agencies are working together to improve children and young people’s mental health across the full spectrum of need.</p><p> </p><p>Later this year, the Government will publish a Green Paper on Children and Young People’s Mental Health focused on helping our youngest and most vulnerable members of society receive the best start in life. This will make sure best practice is being used consistently and will help to accelerate improvements across all services so that children and young people get the right mix of prevention and specialist support.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 29/06/2017 14:46:46 question first ministerially corrected 04/07/2017 15:00:32 answering member 4065 label Biography information for Dame Jackie Doyle-Price previous answer version 791 answering member constituency Thurrock answering member printed Jackie Doyle-Price answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	3973 label Biography information for Grahame Morris

439413

	registered interest
	date	17/12/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Commissioning Groups
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to the Answers of 16 December 2015 to Question 19441 and 20 November 2015 to Question 16648, what the reason is for the apparent difference in the data collection policies on local clinical commissioning groups' spend with independent sector providers described in those Answers.
	tabling member constituency	Liverpool, Wavertree
	tabling member printed	Luciana Berger
	uin	20614
	answer	answer is ministerial correction date of answer 05/01/2016 answer text <p>This corrects the answer<del class="ministerial">s</del> to Question<del class="ministerial">s</del> 16648 <del class="ministerial">and 19441</del>. This was the result of a miscommunication between NHS England and the Department. The total NHS expenditure on non-NHS providers is collected centrally, and is published on page 47 of the Department’s annual report, available from:</p><br /><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/447002/DH_accounts_14-15_web.pdf" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/447002/DH_accounts_14-15_web.pdf</a></p><br /><p>This report divides providers by type (i.e. independent sector providers, voluntary organisations) – it does not specify the different types of services provided.</p><br /> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 05/01/2016 17:56:23 question first ministerially corrected 06/01/2016 10:54:05 answering member 1201 label Biography information for Alistair Burt previous answer version 37629 answering member constituency North East Bedfordshire answering member printed Alistair Burt answering member 1201 label Biography information for Alistair Burt
	tabling member	4036 label Biography information for Luciana Berger

167080

	registered interest
	date	01/12/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Sickle Cell Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much the NHS spends on sickle cell anaemia; and what proportion this is of the total NHS budget.
	tabling member constituency	Wolverhampton South East
	tabling member printed	Mr Pat McFadden
	uin	216527
	answer	answer is ministerial correction date of answer 08/12/2014 answer text <p>There are an estimated 250,000 people with <ins class="ministerial">the</ins> sickle cell <ins class="ministerial">trait</ins> <del class="ministerial">anaemia</del> in the United Kingdom. The Department has made no estimation of the annual cost of treating sickle cell anaemia in the National Health Service nor does it hold information on the total NHS spend on sickle cell anaemia.</p><p> </p><p> </p><p> </p><p>The Department does hold estimated costs for admitted patient care episodes as reported by Healthcare Resource Groups. In 2013-14 the total estimated figure for sickle anaemia was £23.8 million; in 2012-13 it was £21.9 million. This figure does not include other costs such as primary and social care.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 08/12/2014 15:12:22 question first ministerially corrected 10/12/2014 16:29:44 answering member 3918 label Biography information for Jane Ellison previous answer version 32239 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
	tabling member	1587 label Biography information for Pat McFadden

167082

	registered interest
	date	01/12/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Sickle Cell Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what estimate he has made of the annual cost to the NHS of treating sickle cell anaemia.
	tabling member constituency	Wolverhampton South East
	tabling member printed	Mr Pat McFadden
	uin	216529
	answer	answer is ministerial correction date of answer 08/12/2014 answer text <p>There are an estimated 250,000 people with <ins class="ministerial">the</ins> sickle cell <ins class="ministerial">trait</ins> <del class="ministerial">anaemia</del> in the United Kingdom. The Department has made no estimation of the annual cost of treating sickle cell anaemia in the National Health Service nor does it hold information on the total NHS spend on sickle cell anaemia.</p><p> </p><p> </p><p> </p><p>The Department does hold estimated costs for admitted patient care episodes as reported by Healthcare Resource Groups. In 2013-14 the total estimated figure for sickle anaemia was £23.8 million; in 2012-13 it was £21.9 million. This figure does not include other costs such as primary and social care.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 08/12/2014 15:12:22 question first ministerially corrected 10/12/2014 16:29:44 answering member 3918 label Biography information for Jane Ellison previous answer version 32239 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
	tabling member	1587 label Biography information for Pat McFadden

522126

	registered interest
	date	26/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Human Papillomavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether the Medicines and Healthcare Products Regulatory Agency holds any clinical trial data for HPV vaccines which is not in the public domain.
	tabling member constituency	Denton and Reddish
	tabling member printed	Andrew Gwynne
	uin	38833
	answer	answer is ministerial correction date of answer 07/06/2016 answer text <p>There are <del class="ministerial">two</del> <ins class="ministerial">three </ins>human papilloma virus vaccines licensed in the European Union: Cervarix<ins class="ministerial">,</ins> <del class="ministerial">and</del> <ins class="ministerial">Gardasil and </ins>Gardasil 9. These products are licensed centrally throughout Europe by the European Commission via the European Medicines Agency (EMA). Applicants for centrally authorised products are required to submit all relevant supporting clinical trials data, whether published or not, to the EMA directly and not to the Medicines and Healthcare products Regulatory Agency.</p><p> </p><p>Under current medicines legislation, the EMA database registers all EU-approved clinical trials of investigational medicinal products. Since March 2011 this information has been publicly accessible through the EU Clinical Trials Register (except adult Phase 1 trials). The EU Clinical Trials Register includes all EU-conducted trials since May 2004 when the Clinical Trials Directive was implemented and can be found here:</p><p> </p><p><a href="https://www.clinicaltrialsregister.eu/ctr-search/search" target="_blank">https://www.clinicaltrialsregister.eu/ctr-search/search</a></p><p> </p><p>Furthermore since July 2014 clinical trial sponsors have been required to provide a summary of their trial results uploaded onto the EU Clinical Trials Register within one year of their trial completing. There is a two year programme of back-loading underway to provide summaries of trial results for all trials on the Register back to when the EudraCT database was initiated in May 2004.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 07/06/2016 10:57:37 question first ministerially corrected 13/06/2016 10:14:27 answering member 4020 label Biography information for George Freeman previous answer version 2228 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
	tabling member	1506 label Biography information for Andrew Gwynne

754729

	registered interest
	date	20/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pharmacy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the total number of repeat prescriptions issued by (a) high street and (b) internet pharmacies has been in each year since 2007 in (i) England and (ii) each local authority area.
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	uin	6406
	answer	answer is ministerial correction date of answer 11/09/2017 answer text <p>The total number of repeat dispensing prescription items issued by wholly distance selling pharmacies, including internet pharmacies, and other community pharmacies, including those on the high street, for each year since April 2013 in England is detailed in the table below:</p><table><tbody><tr><td><p>Time Period</p></td><td><p>Repeat Dispensing Prescription Items for Distant Selling Pharmacies</p></td><td><p>Repeat Dispensing Prescription Items for Other Community Pharmacies</p></td><td><p>Yearly Total</p></td></tr><tr><td><p>2013 (Apr-Dec 2013)</p></td><td><p>625,157</p></td><td><p>49,222,450</p></td><td><p>49,847,607</p></td></tr><tr><td><p>2014 (Jan-Dec 2014)</p></td><td><p>1,076,060</p></td><td><p>73,769,909</p></td><td><p>74,845,969</p></td></tr><tr><td><p>2015 (Jan-Dec 2015)</p></td><td><p>1,482,942</p></td><td><p>84,411,853</p></td><td><p>85,894,795</p></td></tr><tr><td><p>2016 (Jan-Dec 2016)</p></td><td><p>2,001,326</p></td><td><p>95,730,820</p></td><td><p>97,732,146</p></td></tr><tr><td><p>2017 (Jan-May 2017)</p></td><td><p>930,753</p></td><td><p>42,216,958</p></td><td><p>43,147,711</p></td></tr><tr><td><p>Total</p></td><td><p>6,116,238</p></td><td><p>345,351,990</p></td><td><p>351,468,228</p></td></tr></tbody></table><p>The requested data is not provided before 2013 as the NHS Business Services Authority only holds prescription payment data for a period of 60 months, at which point it is destroyed in line with their records management policy. Also this coincides with NHS England becoming responsible for commissioning community pharmacy services from April 2013. As such, data is attached on repeat dispensing prescription items by NHS England local areas, rather than local authority areas.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/09/2017 14:29:46 question first ministerially corrected 12/09/2017 09:25:45 answering member 4067 label Biography information for Steve Brine attachment 1 file name PQ6406 Repeats appendix FINAL.xlsx title Repeat prescriptions by NHS England area previous answer version 9595 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
	tabling member	4244 label Biography information for Jonathan Ashworth

777814

	registered interest
	date	25/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prescription Drugs: Prices
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, which prescription drugs had the highest increase in price to the NHS in the last 10 years for which data is available.
	tabling member constituency	Vale of Clwyd
	tabling member printed	Chris Ruane
	uin	109619
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>The table below shows the top five individual medicines <del class="ministerial">and chemicals</del> that have shown the highest increase in <ins class="ministerial">cost</ins> <del class="ministerial">price </del> over the last 10 years for Net Ingredient Cost (NIC) per prescription item <del class="ministerial">and NIC per quantity</del>. Prescription medicines<del class="ministerial">/chemicals</del> have only been included where there was prescribing in both 2006 and 2016.</p><p><ins class="ministerial">For any medicine listed, it does not necessarily mean that the price has increased. For example, the cost per prescription item will be higher if the quantity being prescribed per prescription item has increased.</ins></p><p>This is based on Prescription Cost Analysis (PCA) data. PCA data is based on analysis of all prescriptions dispensed in the community i.e. by community pharmacists and appliance contractors, dispensing doctors, and prescriptions submitted by prescribing doctors for items personally administered in England. PCA data do not cover drugs dispensed in hospitals, including mental health trusts, or private prescriptions.</p><p> </p><p>Costs vary over time due to numerous factors including medicines going off patent and becoming available generically, unlicensed medicines becoming licensed medicines, shortages, the level of competition for generic medicines, as well as centrally agreed pricing schemes such as the Pharmaceutical Price Regulation Scheme.</p><p> </p><p>The Department is working closely with the Competition and Markets Authority on a number of investigations into unwarranted price rises of unbranded generic medicines. Where companies have breached competition law, we will seek damages and invest that money back into the National Health Service.</p><p> </p><table><tbody><tr><td colspan="4"><p>The top five medicines with the highest increase in Net Ingredient<sup>1</sup> Cost per prescription item<sup>2</sup></p></td></tr><tr><td><p>Drug Name</p></td><td><p>2006</p></td><td><p>2016</p></td><td><p>Increase</p></td></tr><tr><td><p>Orfadin_Cap 10mg</p></td><td><p>£5,436.74</p></td><td><p>£20,030.86</p></td><td><p>£14,594.12</p></td></tr><tr><td><p>Cerezyme_I/V Inf 400u Vl (Dry)</p></td><td><p>£18,143.17</p></td><td><p>£30,397.85</p></td><td><p>£12,254.68</p></td></tr><tr><td><p>Chenodeoxycholic Acid_Cap 250mg</p></td><td><p>£88.57</p></td><td><p>£9,580.10</p></td><td><p>£9,491.54</p></td></tr><tr><td><p>Trientine Dihydroch_Cap 300mg (Old)</p></td><td><p>£218.58</p></td><td><p>£5,488.22</p></td><td><p>£5,269.64</p></td></tr><tr><td><p>Sod Benz_Liq Spec 400mg/5ml</p></td><td><p>£361.95</p></td><td><p>£4,352.92</p></td><td><p>£3,990.96</p></td></tr></tbody></table><p>Source: Prescription Cost Analysis</p><p> </p><p>Notes:</p><p> </p><p><sup>1</sup>NIC is the basic cost of a drug. It does not take account of discounts, dispensing costs, fees or prescription charges income, so the amount the NHS spent will be slightly different.</p><p> </p><p><sup>2</sup>Prescriptions are written on a prescription form known as an FP10. Each single item written on the form is counted as a prescription item.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/11/2017 14:32:18 question first ministerially corrected 12/12/2017 13:55:12 answering member 4067 label Biography information for Steve Brine previous answer version 20077 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
	tabling member	534 label Biography information for Chris Ruane

802162

	registered interest
	date	06/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radiology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the NHS’ capacity to deliver 24-hour interventional radiology (image-guided surgery) services in each region.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	117849
	answer	answer is ministerial correction date of answer 11/12/2017 answer text <p>The seven day services self-assessment survey completed by trusts in March 2017 included information on the availability of clinical interventions, including interventional radiology (IR), on a seven day basis for patients admitted to hospital in an emergency. The data showed that <ins class="ministerial">72.30%</ins><del class="ministerial">73.65%</del> of hospital trusts who responded to this survey (<del class="ministerial">109 </del> <ins class="ministerial">107</ins>out of 148 trusts) stated that IR was available for these patients seven days a week.</p><p> </p><p>Information on the twice yearly collection is available on the NHS England website at:</p><p><a href="https://www.england.nhs.uk/seven-day-hospital-services/progress" target="_blank">https://www.england.nhs.uk/seven-day-hospital-services/progress</a></p><p>National Health Service regions have access to this report and will be able to consider any variation.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne question first answered 11/12/2017 17:57:45 question first ministerially corrected 26/01/2018 14:08:27 answering member 1542 label Biography information for Philip Dunne previous answer version 28792 answering member constituency Ludlow answering member printed Mr Philip Dunne answering member 1542 label Biography information for Philip Dunne
	tabling member	298 label Biography information for Steve McCabe

169515

	registered interest
	date	10/12/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Professions: Regulation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what amount each of the healthcare regulators charged for annual registration fees in each of the last five years.
	tabling member constituency	Copeland
	tabling member printed	Mr Jamie Reed
	uin	218058
	answer	answer is ministerial correction date of answer 15/12/2014 answer text <p>The regulatory bodies are independent and it is therefore for them to set their fees appropriately. All professional regulators, are aware of the Governments position, as set out in the 2011 Command Paper, `Enabling Excellence’, that we would not expect registration fees to increase, unless there is a clear and strong case that any increase is essential to ensure the exercise of statutory duties.</p><p> </p><p>There are eight Healthcare Professions Regulatory Bodies (excluding the Pharmaceutical Society in Northern Ireland where responsibility is devolved to the Northern Ireland Assembly). The Department does not hold information on the fees of the regulatory bodies. However, we have obtained data from each of the regulatory bodies on the Annual Retention Fee for the last five years which shows:</p><p> </p><p> </p><p>Annual Retention Fee for Healthcare Professions Regulatory Bodies 2010-2015</p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Nursing and Midwifery Council</p></td><td><p>Health and Care Professions Council</p></td><td><p>General Optical Council</p></td><td><p>General Medical Council</p></td><td><p>General Osteopathic Council</p></td><td><p>General Pharmaceutical Council</p></td><td><p>General Dental Council</p></td><td><p>General Chiropractic Council</p></td></tr><tr><td><p>2014-15</p></td><td><p>£100</p></td><td><p>£80</p></td><td><p>£290</p></td><td><p>£390</p></td><td><p>£570</p></td><td><p>£240</p></td><td><p>£576</p></td><td><p>£800</p></td></tr><tr><td><p>2013-14</p></td><td><p>£100</p></td><td><p>£76</p></td><td><p>£260</p></td><td><p>£390</p></td><td><p>£610</p></td><td><p>£240</p></td><td><p>£576</p></td><td><p>£800</p></td></tr><tr><td><p>2012-13</p></td><td><p>£76</p></td><td><p>£76</p></td><td><p>£260</p></td><td><p>£390</p></td><td><p>£655</p></td><td><p>£240</p></td><td><p>£576</p></td><td><p>£800</p></td></tr><tr><td><p>2011-12</p></td><td><p>£76</p></td><td><p>£76</p></td><td><p>£270</p></td><td><p>£390</p></td><td><p>£750</p></td><td><p>£267</p></td><td><p>£576</p></td><td><p>£800</p></td></tr><tr><td><p>2010 -11</p></td><td><p>£76</p></td><td><p>£76</p></td><td><p>£280 (Dispensing optician)</p><p>£325 (Optometrist)</p></td><td><p>£420</p></td><td><p>£750</p></td><td><p>£262</p></td><td><p>£438</p></td><td><p>£1,000</p></td></tr></tbody></table><p> </p><p> </p><p>The Department does not hold data on the number of investigations that have been carried out by each of the healthcare professions regulatory bodies. We understand that this information is published by each of the regulatory bodies.</p><p> </p><p>The Department has five national bodies which have regulatory functions. They are the Care Quality Commission, Monitor, the Human Fertilisation and Embryology Authority, the Human Tissue Authority and the Medicines and Healthcare products Regulatory Agency. None of these bodies charge an annual registration fee but <ins class="ministerial">all except Monitor </ins><del class="ministerial">they do</del> receive income from a range of fees that are applied.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 15/12/2014 17:43:27 question first ministerially corrected 18/12/2014 14:09:00 answering member 3932 label Biography information for Dr Dan Poulter previous answer version 33732 answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	1503 label Biography information for Mr Jamie Reed

599539

	registered interest
	date	11/10/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Circle
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment his Department has made of the potential effect of decisions taken by Circle Holdings PLC in the delivery of musculoskeletal services in Greenwich on the financial capacity of the local healthcare trust to sustain accident and emergency services at University Hospital Lewisham and Queen Elizabeth Hospital Woolwich; and if he will make a statement.
	tabling member constituency	Eltham
	tabling member printed	Clive Efford
	uin	48002
	answer	answer is ministerial correction date of answer 17/10/2016 answer text <p>The procurement of local health services by means of competitive tendering is a matter for the local National Health Service.</p><p> </p><p>We are advised by NHS England that Greenwich Clinical Commissioning Group’s Turnaround Director and Musculoskeletal (MSK) Programme Manager met the senior management team of Lewisham and Greenwich Healthcare Trust in March 2016. We understand that the implications of the MSK service procurement were discussed in detail, and that there were no concerns with regard to the viability of any other services the Trust provides.</p><p> </p><p>We are further advised by NHS England that it undertook an assurance of the procurement process for the MSK service in Greenwich in August 2016<ins class="ministerial">. We also understand that NHS Improvement was aware of the procurement and briefly discussed it with the Trust during a standing monthly meeting on 21 June 2016. </ins> <del class="ministerial">and as part of this also met with the Trust to discuss the implications of the procurement for the trust.</del></p><p>We understand that Circle Health has been engaging with Lewisham and Greenwich Healthcare Trust as part of the mobilisation process, including developing clinical and operational delivery plans to provide integrated services.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne question first answered 17/10/2016 16:19:10 question first ministerially corrected 17/11/2016 14:14:49 answering member 1542 label Biography information for Philip Dunne previous answer version 14633 answering member constituency Ludlow answering member printed Mr Philip Dunne answering member 1542 label Biography information for Philip Dunne
	tabling member	165 label Biography information for Clive Efford